Trevena

Trevena’s Investigator-Led RELIEVE Study Accepted for Presentation at 2024 American Burn Association Meeting

CHESTERBROOK, PA — Biopharmaceutical company Trevena, Inc. (Nasdaq: TRVN), known for its innovative work in developing and commercializing novel medicines for central nervous system disorders, recently announced the acceptance of …

Trevena’s Investigator-Led RELIEVE Study Accepted for Presentation at 2024 American Burn Association Meeting Read More


Panavance Therapeutics

Panavance Therapeutics’ Cancer Drug Misetionamide Shows Promising Results in Melanoma Treatment

BERWYN, PA — Chester County-based biotech company, Panavance Therapeutics Inc., has announced the recent publication of positive data in the International Journal of Molecular Sciences about the anti-tumor activity of …

Panavance Therapeutics’ Cancer Drug Misetionamide Shows Promising Results in Melanoma Treatment Read More

Baby

CDC Announces Release of Over 77,000 Additional Doses of Beyfortus™ for RSV Protection in Infants

The Centers for Disease Control and Prevention (CDC) has recently announced the release of more than 77,000 additional doses of Beyfortus™ (nirsevimab-alip (100 mg)), a long-acting monoclonal antibody designed to …

CDC Announces Release of Over 77,000 Additional Doses of Beyfortus™ for RSV Protection in Infants Read More

Teleflex

Teleflex Launches ACCESS-MANTA Registry to Evaluate MANTA Vascular Closure Device

WAYNE, PA — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, has announced the first patient enrollment in the ACCESS-MANTA™ Registry. This international, multicenter, prospective, observational, single-arm …

Teleflex Launches ACCESS-MANTA Registry to Evaluate MANTA Vascular Closure Device Read More